middle.news
How Will Imugene’s $20M Raise Propel Azer-cel’s Clinical Trials?
1:52pm on Wednesday 11th of March, 2026 AEDT
•
Healthcare
Read Story
How Will Imugene’s $20M Raise Propel Azer-cel’s Clinical Trials?
1:52pm on Wednesday 11th of March, 2026 AEDT
Key Points
Firm commitments for $12 million placement at $0.18 per share
Share Purchase Plan to raise up to $8 million from existing shareholders
Free attaching options and piggyback options offered to investors
Funds to expand Phase 1b azer-cel clinical trial cohorts
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Imugene (ASX:IMU)
OPEN ARTICLE